Clinical Guides
Pulmonary Embolism
A clinically focused guide to probability-led diagnosis, urgent imaging and anticoagulation decisions for suspected or confirmed pulmonary embolism in India, with high-risk presentations kept under specialist emergency care.
MedNext Academy | 16 min read
Pulmonary Embolism
A clinically focused guide to probability-led diagnosis, urgent imaging and anticoagulation decisions for suspected or confirmed pulmonary embolism in India, with high-risk presentations kept under specialist emergency care.
Summary
Pulmonary embolism (PE) is obstruction of pulmonary arterial circulation, usually by thrombus arising from deep veins. It can range from a small stable embolus to acute right-ventricular failure, shock or cardiac arrest. Breathlessness, pleuritic chest pain, cough, haemoptysis, syncope, tachycardia or unexplained hypoxaemia are compatible with PE but none confirms it. The safe approach is not to order a D-dimer for every chest symptom or to dismiss risk because the examination is normal. First assess haemodynamic and respiratory stability, consider immediately dangerous alternatives, estimate pre-test probability with an accepted pathway, then obtain the indicated imaging without unsafe delay.
Current guidelines recommends a two-level PE Wells score in people with suspected PE. In that pathway, a score above four is PE likely and should lead to immediate CTPA when possible, or an appropriate V/Q option when contrast, severe renal impairment or irradiation risk makes CTPA unsuitable. A score of four or less is PE unlikely and should lead to a timely D-dimer pathway; if D-dimer or imaging cannot be obtained promptly, interim therapeutic anticoagulation is considered after bleeding risk is assessed. A negative D-dimer is meaningful only in the clinical setting and assay pathway in which it is validated.
Confirmed PE requires anticoagulation unless it is contraindicated, with drug choice governed by haemodynamic state, bleeding risk, pregnancy, renal function, cancer, antiphospholipid syndrome, weight, interactions, access and adherence. Haemodynamic instability is an emergency. Reperfusion treatment, catheter therapy, surgery and intensive support belong to an experienced emergency, critical-care and specialist team; a stable outpatient-style anticoagulation plan must never be copied into shock. This draft is educational, reviewed and has been reviewed by the MedNext Clinical Team. It does not replace local emergency protocols, imaging interpretation, anticoagulant dosing or specialist decision-making.
How Common Is It?
PE is part of venous thromboembolism (VTE), a disease spectrum that includes deep-vein thrombosis. Its measured incidence depends on age, diagnostic access, hospital surveillance, cancer prevalence and coding practices. It is not safe to convert a rate from a different healthcare system into an individual probability or a national Indian burden estimate. What matters at the bedside is the combination of current symptoms, physiological status and transient or persistent provoking factors. A previously well young person can have PE in pregnancy or after surgery, while an older inpatient with several risks may have an alternative explanation for breathlessness.
PE matters because deterioration can be rapid, but over-testing and unnecessary anticoagulation also cause harm. D-dimer is often elevated in hospitalised patients, infection, cancer, inflammation, pregnancy, older age and after surgery; it is not a standalone diagnosis. CTPA identifies clot in pulmonary arteries but exposes people to contrast and radiation, and its result must be interpreted with pre-test probability and image quality. V/Q imaging and lower-limb ultrasound have particular roles when contrast is unsuitable or pregnancy changes the risk-benefit balance.
In India, access to CTPA, V/Q scanning, echocardiography, blood products, intensive care, anti-Xa monitoring and specialist thrombosis care varies considerably. Long transfers or cost can delay diagnosis, which strengthens the need for a documented probability assessment, explicit anticoagulation-versus-bleeding decision and early referral to a facility with the necessary capability. Resource constraint does not justify a guessed diagnosis, a non-validated D-dimer shortcut or treatment without a plan for monitoring and rescue.
Risk Factors
Elicit provoking factors and persistent risks without treating them as proof. Recent hospital admission, surgery, trauma, reduced mobility, previous VTE, active cancer, pregnancy or the puerperium, oestrogen exposure, acute medical illness, central venous devices and inherited or acquired thrombophilia can increase VTE risk. The Wells score includes clinical DVT signs, alternative diagnosis judged less likely than PE, tachycardia, recent immobilisation or surgery, previous DVT or PE, haemoptysis and active cancer; it is a structured estimate, not a replacement for clinical judgement or a diagnosis.
The context changes testing and treatment. Pregnancy and the period after delivery require obstetric and haematology or thrombosis coordination. Active cancer raises both thrombosis and bleeding risk, and tumour site, treatment interactions, thrombocytopenia, mucosal lesions, renal function and prognosis influence anticoagulant choice. Renal impairment changes clearance of several agents; liver disease, prior bleeding, concurrent antiplatelet or non-steroidal anti-inflammatory therapy, uncontrolled hypertension, recent surgery, intracranial disease and poor adherence can magnify bleeding risk. A negative family history does not exclude VTE, while indiscriminate thrombophilia testing during acute treatment is often misleading and rarely changes immediate care.
Ask about infection, tuberculosis and anaemia when relevant in India, but do not use them as generic explanations for pleuritic pain or dyspnoea. Recent long-distance travel, dehydration, obesity and smoking may contribute in context but should not eclipse stronger factors or alternative diagnoses. “Unprovoked” means no major transient provoking factor is identified after appropriate assessment; it does not mean there was no biology or that a thrombophilia panel must be ordered. Recurrence prevention depends on a documented balance of recurrence risk, bleeding risk and patient preference after the initial treatment phase.
Diagnosis
History
Establish onset, progression, pleuritic or central chest pain, dyspnoea at rest and exertion, haemoptysis, syncope or presyncope, palpitations, cough, fever and unilateral leg pain or swelling. Ask about prior VTE, surgery, hospitalisation, immobilisation, trauma, cancer, pregnancy or postpartum timing, contraception or hormone exposure, prior bleeding, renal or liver disease, current medicines and allergy to contrast. Record baseline functional status and the exact time of last anticoagulant dose if already prescribed. Simultaneously seek alternatives such as acute coronary syndrome, aortic syndrome, pneumonia, pneumothorax, asthma or COPD exacerbation, pericarditis, arrhythmia, heart failure, sepsis and panic symptoms only after physiological illness has been assessed.
Examination
Record pulse, blood pressure, respiratory rate, oxygen saturation, temperature, mental status and work of breathing. Look for shock, cyanosis, raised jugular venous pressure, signs of right-heart strain, unilateral leg swelling, calf tenderness, signs of infection, wheeze, crackles, focal neurological deficit and evidence of bleeding. A normal examination or oxygen saturation does not exclude PE. Hypotension, altered mental status, cold clammy skin, severe hypoxaemia, syncope with ongoing instability or cardiac arrest changes the pathway immediately: resuscitation, urgent senior support and bedside imaging must proceed in parallel rather than waiting for a D-dimer.
Investigations
For stable suspected PE, use a validated probability pathway. Current guidelines recommends the two-level Wells score. With a likely score of more than four, arrange CTPA immediately if possible; V/Q SPECT or, if unavailable, V/Q planar imaging is an alternative when contrast allergy, severe renal impairment defined in current guidelines as estimated creatinine clearance below 30 ml/min, or irradiation risk makes CTPA unsuitable. With an unlikely score of four or less, obtain a D-dimer promptly; a positive result proceeds to imaging, while a negative result in the validated pathway prompts reconsideration of other diagnoses. Consider an age-adjusted D-dimer threshold for people over 50 when using an appropriate assay.
Electrocardiography, chest radiography, full blood count, renal and hepatic function, coagulation studies, troponin, arterial or venous blood gas and pregnancy testing may inform differential diagnosis, safety or risk stratification, but none alone rules PE in or out. Compression ultrasound can establish proximal DVT in selected pathways and can be useful when chest imaging is delayed or unsuitable. Echocardiography is vital in unstable suspected PE to identify right-ventricular pressure overload and exclude other catastrophic causes, but it does not replace definitive imaging in a stable patient. The imaging report, image quality and clinical probability must be documented before a long-term diagnosis is attached.
Differential Diagnosis
Acute coronary syndrome, aortic dissection, myocarditis, pericarditis, arrhythmia and acute heart failure can present with chest pain, dyspnoea, tachycardia, syncope or elevated troponin. A raised troponin in PE may indicate right-ventricular strain but never removes the need to consider coronary disease. Pneumonia, tuberculosis when clinically supported, viral respiratory infection, pleural effusion, pneumothorax, asthma, COPD exacerbation and aspiration may cause breathlessness and pleuritic pain. Fever or a raised inflammatory marker does not exclude PE, especially in a person with cancer or recent hospitalisation.
Anaemia, metabolic acidosis, sepsis, pregnancy-related cardiomyopathy, pulmonary hypertension and deconditioning can coexist with or mimic PE. In pregnancy and postpartum, consider obstetric haemorrhage, pre-eclampsia with pulmonary oedema, amniotic fluid embolism around delivery, pneumonia, asthma and cardiac disease. Syncope can arise from arrhythmia, haemorrhage, seizure, vasovagal events or structural heart disease. Sudden unilateral leg swelling can be DVT but also cellulitis, muscle injury, ruptured Baker cyst, venous insufficiency or lymphatic obstruction.
Anxiety can accompany dyspnoea and chest discomfort but should not be assigned before adequate assessment of physiology and dangerous alternatives. Conversely, a positive D-dimer does not convert anxiety or infection into PE; it triggers imaging only within the probability pathway. A technically limited scan, discordance between clinical probability and imaging, recurrent symptoms on anticoagulation, unexplained severe pulmonary hypertension or persistent functional limitation merits specialist reconsideration. The goal is a coherent diagnosis with documented evidence, not a reassuring label at the cost of missed disease or unnecessary anticoagulation.
Management
Stabilise first. Give oxygen when clinically required, establish monitoring and intravenous access, treat shock according to emergency protocols, and obtain urgent senior critical-care, cardiology, respiratory, emergency-medicine and radiology support according to local availability. ESC defines high-risk acute PE by haemodynamic instability, including cardiac arrest, obstructive shock or persistent hypotension; the full definition and treatment decision require the guideline and emergency team, not an informal blood-pressure cutoff in this guide. In an unstable person with suspected PE, bedside echocardiography or focused imaging may support an emergency decision when immediate CTPA is impossible, while urgent reperfusion options are considered by the specialist team.
For stable suspected PE, follow the probability-imaging pathway without delay. If imaging cannot be performed immediately in a person with likely PE, current guidelines recommends interim therapeutic anticoagulation after considering contraindications. In a person with unlikely PE, if a D-dimer result cannot be obtained within four hours, current guidelines likewise recommends interim therapeutic anticoagulation while awaiting the result. Obtain baseline full blood count, renal and hepatic function, PT and APTT, but current guidelines says not to delay starting interim anticoagulation solely to wait for those results; review the results within 24 hours. Consider active bleeding, recent high-risk surgery, thrombocytopenia, major trauma, intracranial pathology, severe uncontrolled hypertension, renal function and interacting medicines before treatment, and document the decision.
For confirmed PE, current guidelines recommends anticoagulation for at least three months unless contraindicated. Drug and dose selection is not generic: apixaban or rivaroxaban are options in the current pathway for many adults, while low-molecular-weight heparin followed by dabigatran or edoxaban, or low-molecular-weight heparin with a vitamin-K antagonist bridge, are alternatives where appropriate. Pregnancy, active cancer, severe renal impairment, established triple-positive antiphospholipid syndrome, extremes of weight, bleeding risk and interactions change this choice. Use the exact national, institutional and product-label dosing protocol; do not extrapolate a dose from this educational guide.
Routine thrombolysis is not a treatment for every large clot on CTPA or every elevated troponin. In high-risk PE with haemodynamic instability, systemic thrombolysis is the usual reperfusion approach in the ESC guideline when appropriate; surgical embolectomy or catheter-directed treatment may be considered where thrombolysis is contraindicated or has failed and expertise exists. Intermediate-risk patients need monitored risk assessment, and rescue reperfusion is considered if haemodynamic deterioration occurs. Major bleeding, intracranial haemorrhage risk, recent surgery and other contraindications must be weighed by the emergency team. Inferior vena cava filters are not a substitute for anticoagulation and require a specific specialist indication.
Early discharge or ambulatory management is only for carefully selected low-risk, stable patients with a confirmed diagnosis, low bleeding risk, reliable medication access, social support and an agreed monitoring and follow-up plan. It is unsafe in shock, hypoxaemia needing support, high bleeding risk, major comorbidity, pregnancy without coordinated care, uncertain diagnosis or inability to return urgently.
Prescribing Information
Anticoagulation is high-risk prescribing. Before interim or confirmed-treatment anticoagulation, record indication, body weight where the selected protocol requires it, renal and hepatic function, full blood count, bleeding history, pregnancy status, cancer, concomitant antiplatelets, anti-inflammatory drugs, anticonvulsants, antimicrobials, herbal products and adherence barriers. Current guidelines specifies baseline full blood count, renal and hepatic function, PT and APTT for interim therapeutic anticoagulation and asks clinicians not to wait for the results before treatment when anticoagulation is indicated, while ensuring review within 24 hours. A prescriber must still choose the exact agent and dose from the current protocol and product information.
Current guidelines recommends at least three months of anticoagulation for confirmed PE, then an explicit continuation-versus-stop discussion. After a provoked PE where the provoking factor has resolved and the course is uncomplicated, stopping at three months may be considered. For unprovoked PE, continuing beyond three months may be considered after balancing recurrence and bleeding risk; risk scores must not be the only basis for a long-term decision. For active cancer, current guidelines recommends treatment for three to six months with review at that interval, and specifically requires consideration of tumour site, cancer-treatment interactions and bleeding risk.
Pregnancy changes both diagnosis and drug selection. ASH recommends low-molecular-weight heparin rather than unfractionated heparin for acute VTE in pregnancy and recommends against direct oral anticoagulants during pregnancy; the exact dose, monitoring and duration require obstetric-haematology or thrombosis input. After delivery, anticoagulant selection must account for bleeding, neuraxial procedures, breastfeeding and local product information. Renal impairment may require a different agent or monitoring strategy, while established triple-positive antiphospholipid syndrome may favour a vitamin-K antagonist pathway rather than a direct oral anticoagulant. Do not use a normal creatinine, a prior prescription or a generic internet dose as proof that a particular anticoagulant is safe today.
Give clear medicine safety-netting: take the dose exactly as prescribed, do not double after a missed dose without product-specific advice, avoid new over-the-counter anti-inflammatory medicines or supplements without a pharmacist or prescriber check, and seek urgent help for major bleeding, black stools, haematemesis, severe headache, head injury, collapse, pregnancy concerns or new dyspnoea or chest pain. At every transition of care, reconcile the drug name, formulation, dose, indication, intended duration, renal function, monitoring responsibility and the date of review.
When to Refer
Call emergency services or arrange urgent transfer for haemodynamic instability, syncope with persistent abnormal physiology, severe hypoxaemia, cardiac arrest, major bleeding, suspected high-risk PE, pregnancy with suspected or confirmed PE needing coordinated care, or inability to obtain essential imaging and rescue support locally. Referral is not a delay tactic: initiate resuscitation and the locally approved suspected-PE pathway while transfer is organised. Communicate vital signs and trend, oxygen requirement, probability assessment, bleeding risk, anticoagulant name and timing, pregnancy status, renal function, ECG, imaging, troponin and full medication list.
Refer to a physician, respiratory, cardiology, haematology, oncology or thrombosis service according to the problem: uncertain imaging; recurrent VTE; unprovoked PE needing duration review; cancer-associated thrombosis; severe renal or hepatic dysfunction; antiphospholipid syndrome; pregnancy; major bleeding; suspected chronic thromboembolic pulmonary hypertension; or difficulty obtaining or adhering to anticoagulation. A person with persistent breathlessness, reduced exercise tolerance, chest pain, syncope or signs of pulmonary hypertension after PE needs planned reassessment rather than reassurance that every symptom is anxiety or deconditioning.
In India, name the capability needed at the receiving centre: CTPA or V/Q imaging, radiology interpretation, bedside echocardiography, ICU, blood products, thrombolysis or embolectomy, obstetric anaesthesia, cancer care or anticoagulation monitoring. Confirm destination, transport, imaging transfer, payment or public-service pathway where relevant and a contact route if symptoms worsen. Discharge from an emergency department or district hospital is appropriate only when the care plan is actually available, not merely written.
Red Flags
Immediate emergency care is required for collapse, cardiac arrest, persistent hypotension, obstructive-shock features, altered mental status, severe respiratory distress, cyanosis, worsening oxygen requirement, recurrent syncope, severe chest pain or haemoptysis with instability. These may be high-risk PE or another catastrophic diagnosis such as acute coronary syndrome, aortic dissection, tension pneumothorax, sepsis or major haemorrhage. Do not wait for a D-dimer, an outpatient ultrasound appointment or a routine clinic referral.
Major anticoagulant complications require urgent response: haematemesis, melaena, heavy vaginal bleeding, haematuria with systemic symptoms, uncontrolled epistaxis, new focal neurological deficit, severe sudden headache, seizure, confusion, collapse or any significant head injury while anticoagulated. Bring the anticoagulant package and exact last-dose time. Do not independently take an extra dose to “cover” new chest symptoms, and do not stop a prescribed anticoagulant after minor bruising without speaking to the treating service unless emergency clinicians advise otherwise.
Pregnancy or postpartum status with chest pain, breathlessness, syncope or unilateral leg swelling is an urgent obstetric-medical presentation. New fever, pleuritic pain or hypoxaemia in a person with cancer, recent surgery or immobility similarly warrants prompt assessment even if an earlier test was negative. Persistent symptoms after treated PE, particularly progressive dyspnoea, presyncope or reduced exercise capacity, need follow-up for recurrence, bleeding, drug adherence, alternate cardiopulmonary disease and chronic thromboembolic complications. Red flags supersede routine duration or outpatient follow-up plans.
Indian Clinical Context
This guide uses current guidelines, ESC and ASH sources because they are transparent, current professional references; their jurisdictional recommendations are not automatically Indian legal, formulary or reimbursement rules. In India, follow the local emergency department, hospital, obstetric and anticoagulation protocols, the product information for the medicine that is actually supplied, and applicable national programmes. Do not substitute a D-dimer assay, a Wells implementation, CTPA report or anticoagulant formulation without validating it locally. Laboratory turnaround, contrast availability, V/Q access and renal-function reporting can change the safe pathway.
When CTPA is unavailable, the appropriate response is early senior discussion and transfer planning, not a guessed PE diagnosis based solely on symptoms or D-dimer. When an interim anticoagulation decision is made, document the reason for imaging delay, bleeding assessment, agent selected under local protocol, baseline samples, last known renal function, review responsibility and the receiving centre. Patients should be given written signs of recurrent PE and bleeding in a language they understand, with a real contact route. Cost, travel, pharmacy availability and family support are clinical safety factors because missed doses and unplanned interruption can be dangerous.
Tuberculosis, anaemia, pregnancy, infection and cardiometabolic disease are common differential or coexisting considerations in Indian practice, but none permits anchoring away from PE. Cancer and maternity services may be located in separate facilities; explicitly coordinate communication and avoid leaving the patient to reconcile conflicting instructions. The NMC curriculum supports structured assessment of acute breathlessness, emergency stabilisation, rational investigation, safe prescribing and referral. It does not make an undergraduate independently competent to give thrombolysis, select complex anticoagulation or interpret CTPA in isolation.
NMC Competency Mapping
The NMC CBME Curriculum 2024 supplies the educational framework for an undergraduate approach to acute cardiorespiratory symptoms: focused history, assessment of physiological stability, examination, differential diagnosis, rational investigations, initial emergency management, safe prescribing and referral. In a suspected PE scenario, the learner should first recognise the sick patient, record observations, seek senior help, consider competing immediately dangerous diagnoses and communicate urgency clearly.
The learner should understand probability-led testing rather than treating D-dimer as a screening test for all dyspnoea. They should be able to explain the purpose of the Wells score, the broad roles of D-dimer, CTPA, V/Q imaging, ultrasound and echocardiography, and why pregnancy, renal impairment, cancer and bleeding risk change the pathway. They should document time-critical facts such as last anticoagulant dose, pregnancy status, allergies, renal function, active bleeding and transfer arrangements.
Competence includes knowing the limits of practice. Anticoagulant choice and dosing, thrombolysis, catheter intervention, embolectomy, ICU support and duration decisions for cancer, pregnancy, renal disease or antiphospholipid syndrome require current local protocol and specialist supervision. A learner should give safe red-flag advice, medication reconciliation and follow-up communication, while never reassuring an unstable patient or delaying transfer for a score calculation. Assessment should favour physiological reasoning and safe escalation over memorised anticoagulant doses.
Key Exam Pearls for NEET PG
PE is a probability-and-imaging diagnosis. Symptoms, ECG changes, hypoxaemia, troponin elevation and D-dimer can support concern but none proves PE in isolation. In the current guidelines two-level pathway, a Wells score above four is PE likely and moves to immediate CTPA when possible; a score of four or less moves to D-dimer. A positive D-dimer is not diagnostic, and a negative D-dimer should be interpreted only in the appropriate validated clinical pathway.
For a stable patient, identify contraindications or alternatives to CTPA and do not forget pregnancy and renal function. For an unstable patient, resuscitation and senior emergency care run in parallel with bedside imaging; do not wait for routine D-dimer testing. ESC high-risk PE is defined by haemodynamic instability, not simply a dramatic CT appearance. Systemic thrombolysis is a specialist reperfusion decision for high-risk disease when appropriate, with bleeding contraindications considered.
Confirmed PE needs anticoagulation for at least three months in the current guidance, followed by recurrence-versus-bleeding review. Active cancer, pregnancy, severe renal dysfunction, bleeding, antiphospholipid syndrome and drug interactions make regimen selection non-generic. The exam-safe answer is to state the pathway and need for specialist or protocol-led selection, not to invent a dose. Persistent dyspnoea after PE warrants structured follow-up for recurrence, alternative disease and chronic thromboembolic complications.
Frequently Asked Questions
Does a normal oxygen saturation or normal ECG exclude pulmonary embolism?
No. PE can have normal resting oxygen saturation, a normal or non-specific ECG and a relatively unremarkable chest examination. These findings inform overall assessment and alternative diagnoses but cannot independently rule out PE. Use a validated probability pathway with the appropriate D-dimer or imaging test, while escalating immediately if there is shock, severe respiratory distress, syncope with instability or other red flags.
When is interim anticoagulation considered before imaging is complete?
Current guidelines recommends interim therapeutic anticoagulation for likely PE when definitive imaging cannot be done immediately, and for unlikely PE when a D-dimer result cannot be obtained within four hours. The decision still requires an assessment for active bleeding and other contraindications. Baseline blood tests should be taken, but Current guidelines advises not to delay indicated treatment solely while waiting for those results; they require review within 24 hours.
Can every person with confirmed pulmonary embolism be treated at home?
No. Ambulatory care is reserved for carefully selected stable low-risk patients with confirmed disease, low bleeding risk, reliable medicine access, support and an agreed follow-up plan. Haemodynamic instability, oxygen requirement, major comorbidity, high bleeding risk, diagnostic uncertainty, pregnancy without coordinated care or inability to return urgently requires hospital-based assessment and treatment.
How long is anticoagulation continued after pulmonary embolism?
Current guidelines recommends at least three months for confirmed PE, followed by an explicit recurrence-versus-bleeding review. A resolved provoking factor may support stopping after three months when the course was uncomplicated; unprovoked PE may justify longer treatment. Active cancer has a three-to-six-month initial period with review. Pregnancy, renal function, bleeding, cancer, antiphospholipid syndrome and patient preference require individual specialist or protocol-led decisions.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic